We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
-13.66%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$34.4B
AUM Growth
-$6.59B
(-16%)
Cap. Flow
+$586M
Cap. Flow
% of AUM
1.7%
Top 10 Holdings %
Top 10 Hldgs %
23.16%
Holding
1,447
New
124
Increased
589
Reduced
408
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$95.6M |
| 2 |
Marvell Technology
MRVL
|
+$87.7M |
| 3 |
Adobe
ADBE
|
+$72.3M |
| 4 |
Sherwin-Williams
SHW
|
+$64.7M |
| 5 |
Tesla
TSLA
|
+$58.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$153M |
| 2 |
Deutsche Bank
DB
|
+$102M |
| 3 |
Procter & Gamble
PG
|
+$77.8M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$77.7M |
| 5 |
CERN
Cerner Corp
CERN
|
+$61.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.3% |
| 2 | Healthcare | 19.53% |
| 3 | Financials | 10.69% |
| 4 | Consumer Discretionary | 8.7% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Ascendis Pharma A/S
ASND
$16.7B
| $1.39M | ﹤0.01% |
15,060
-9,000
| -37% | -$848K |
|
|
RCM
802
DELISTED
R1 RCM Inc. Common Stock
RCM
| $1.39M | ﹤0.01% |
66,925
+11,438
| +21% | +$259K |
|
|
BERY
803
DELISTED
Berry Global Group, Inc.
BERY
| $1.38M | ﹤0.01% |
27,987
| – | – |
|
|
TWOU
804
DELISTED
2U Inc
TWOU
| $1.38M | ﹤0.01% |
4,329
-9,400
| -68% | -$2.9M |
|
805
Banco Bradesco
BBD
$35.2B
| $1.38M | ﹤0.01% |
414,268
+137,499
| +50% | +$528K |
|
806
Sweetgreen
SG
$658M
| $1.37M | ﹤0.01% |
+121,500
| New | +$2.56M |
|
807
Teck Resources
TECK
$32.7B
| $1.36M | ﹤0.01% |
43,357
+14,803
| +52% | +$584K |
|
808
Lincoln National
LNC
$8.6B
| $1.35M | ﹤0.01% |
28,992
-1,660
| -5% | -$94.7K |
|
809
Guardant Health
GH
$22.4B
| $1.35M | ﹤0.01% |
32,550
| – | – |
|
810
Arvinas
ARVN
$586M
| $1.34M | ﹤0.01% |
30,800
| – | – |
|
811
POSCO
PKX
$17.3B
| $1.34M | ﹤0.01% |
29,517
+2,500
| +9% | +$138K |
|
812
Iovance Biotherapeutics
IOVA
$2.89B
| $1.33M | ﹤0.01% |
123,900
| – | – |
|
813
Burlington
BURL
$23.1B
| $1.33M | ﹤0.01% |
9,341
+210
| +2% | +$38K |
|
814
Meritage Homes
MTH
$4.79B
| $1.32M | ﹤0.01% |
37,256
-2,538
| -6% | -$101K |
|
|
HI
815
DELISTED
Hillenbrand
HI
| $1.32M | ﹤0.01% |
32,800
| – | – |
|
816
Franklin Resources
BEN
$17.1B
| $1.31M | ﹤0.01% |
57,556
-344
| -0.6% | -$8.8K |
|
817
Liberty Global Class A
LBTYA
$3.5B
| $1.3M | ﹤0.01% |
59,180
+37,693
| +175% | +$884K |
|
818
Novavax
NVAX
$1.28B
| $1.3M | ﹤0.01% |
25,850
-13,745
| -35% | -$712K |
|
|
BPMC
819
DELISTED
Blueprint Medicines
BPMC
| $1.28M | ﹤0.01% |
25,150
| – | – |
|
820
BorgWarner
BWA
$14.1B
| $1.26M | ﹤0.01% |
41,195
+2,896
| +8% | +$95.4K |
|
821
Allison Transmission
ALSN
$10.3B
| $1.24M | ﹤0.01% |
32,850
+3,690
| +13% | +$141K |
|
822
Enact Holdings
ACT
$6.77B
| $1.24M | ﹤0.01% |
+58,300
| New | +$1.33M |
|
823
ACI Worldwide
ACIW
$5.31B
| $1.23M | ﹤0.01% |
+48,000
| New | +$1.29M |
|
824
MarketAxess Holdings
MKTX
$5.72B
| $1.23M | ﹤0.01% |
4,771
+763
| +19% | +$209K |
|
825
Alkermes
ALKS
$8.32B
| $1.23M | ﹤0.01% |
41,350
| – | – |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q2 2022 Portfolio in Review
As of Q2 2022, DekaBank Deutsche Girozentrale held 1,447 positions worth $34.4B, down 16% from $41B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
DekaBank Deutsche Girozentrale's Q2 2022 filing shows 124 new, 589 increased, 408 reduced and 84 closed positions. Its largest new stake was Marvell Technology: 1,546,996 shares worth $67.3M. The largest sale was Linde, an estimated $153M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- DekaBank Deutsche Girozentrale's largest Q2 2022 buy was Marvell Technology: 1,546,996 shares worth $67.3M.
- DekaBank Deutsche Girozentrale added most to Meta Platforms (Facebook) in Q2 2022, an estimated $95.6M increase.
- DekaBank Deutsche Girozentrale's biggest Q2 2022 reduction was Linde, cutting an estimated $153M.
- DekaBank Deutsche Girozentrale fully exited Cerner Corp in Q2 2022, selling an estimated $61.9M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 23% of its $34.4B portfolio in Q2 2022.
- DekaBank Deutsche Girozentrale opened 124 new positions and closed 84 in Q2 2022.
- DekaBank Deutsche Girozentrale's portfolio value fell 16% quarter-over-quarter to $34.4B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2022, filed 3 Aug 2022.